Zevra Therapeutics (ZVRA) Goodwill & Intangibles (2023 - 2026)

Zevra Therapeutics (ZVRA) has 4 years of Goodwill & Intangibles data on file, last reported at $10.8 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 83.3% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (down 83.3% YoY) and the FY2025 annual result came in at $11.1 million, down 84.91% from the prior year.
• Goodwill & Intangibles declined to $10.8 million in Q1 2026, from $11.1 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $73.9 million in Q4 2023 to a low of $6.7 million in Q3 2024.
• A 4-year average of $34.2 million and a median of $11.6 million in 2025 frame the typical range for Goodwill & Intangibles.
• The widest YoY moves for Goodwill & Intangibles: up 865.54% in 2025, down 84.91% in 2025.
• Tracing ZVRA's Goodwill & Intangibles over 4 years: stood at $73.9 million in 2023, then dropped by 0.32% to $73.7 million in 2024, then tumbled by 84.91% to $11.1 million in 2025, then retreated by 2.83% to $10.8 million in 2026.
• The last three Goodwill & Intangibles figures came in at $10.8 million (Q1 2026), $11.1 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.